Device for noninvasive brain biopsies via blood draw moves closer to market approval

FDA grants WashU-based technology ‘Breakthrough Device’ designation A device aimed at enabling neurosurgeons and other physicians to perform noninvasive blood-based biopsies in adults with brain tumors has received Food and Drug Administration (FDA) “Breakthrough Device” designation. The device includes technology from Washington University in St. Louis and developed by Cordance Medical Inc., a medical device […]

Noninvasive, ultrasound-based brain biopsy is feasible, safe in people

Sonobiopsies generate genetic, molecular data to inform treatment decisions for brain diseases The blood-brain barrier, the body’s way of shielding sensitive brain tissue from viruses, toxins and other harmful substances in the blood, can pose a problem for physicians caring for patients with suspected brain diseases such as cancer. Molecular and genetic information would be […]